Frantzeskaki, F.; Konstantonis, D.; Rizos, M.; Kitsinelis, V.; Skyllas, G.; Renieris, I.; Doumani, M.; Kolias, V.; Kefalidi, E.; Angouras, D.; Tsantes, A.; Tsangaris, I. Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics2023, 13, 3496.
Frantzeskaki, F.; Konstantonis, D.; Rizos, M.; Kitsinelis, V.; Skyllas, G.; Renieris, I.; Doumani, M.; Kolias, V.; Kefalidi, E.; Angouras, D.; Tsantes, A.; Tsangaris, I. Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics 2023, 13, 3496.
Frantzeskaki, F.; Konstantonis, D.; Rizos, M.; Kitsinelis, V.; Skyllas, G.; Renieris, I.; Doumani, M.; Kolias, V.; Kefalidi, E.; Angouras, D.; Tsantes, A.; Tsangaris, I. Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics2023, 13, 3496.
Frantzeskaki, F.; Konstantonis, D.; Rizos, M.; Kitsinelis, V.; Skyllas, G.; Renieris, I.; Doumani, M.; Kolias, V.; Kefalidi, E.; Angouras, D.; Tsantes, A.; Tsangaris, I. Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics 2023, 13, 3496.
Abstract
Extracorporeal membrane oxygenation (ECMO) is used for the management of severe respiratory and cardiac failure, as well as bridge to definite treatment or transplantation. ECMO associated coagulopathy (EAC) is a frequent complication leading to high rates of thrombosis or severe haemorrhage, contributing to morbidity and mortality of patients. Understanding the pathophysiology of EAC is substantial for effectively managing patients on ECMO. We analyse the underlying mechanism of EAC and discuss the monitoring of coagulation profile, combining the viscoelastic point of care assays with the conventional coagulation laboratory tests.
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.